Delivery Order SPE2DB20D3303-SPE2DB24FA0MW

Award Date 6/28/24
Potential Completion Date 7/1/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Pediarix 0.5 ML Syringe 0.5ML, a pharmaceutical product, to the U.S. government. The contract has a ceiling value of $1,228.78 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This federal contract award, valued at $4,929.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of May 7, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,987.54 to Amerisourcebergen Drug Corp's Corporate Office Division to provide PEDIARIX 0.5 ML SYRINGE 0.5ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen supplies a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier. The $5,409.44 firm-fixed-price delivery order is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, with a completion date of July 12, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,032.14 firm fixed-price delivery order is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a medical product used for pediatric vaccination. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order worth $5,571.20 for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML. The contract has a firm fixed price pricing type and an ultimate completion date of March 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,053.90 firm fixed-price delivery order is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of July 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PEDIARIX 0.5 ML SYRINGE 0.S0ML. The award, valued at $42,618.29, is a firm-fixed-price delivery order with an ultimate completion date of August 23, 2024. This contract is not set aside for any specific business type. Amerisourcebergen Drug Corp's Corporate Office division will be responsible for fulfilling this order, which is...
This federal contract award is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML medical supplies to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $10,070.89, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, on July 9, 2024. The contract is a delivery order with a firm fixed price and has an ultimate completion date of July 10, 2024. There is no set-aside designation...
This federal contract award, valued at $14,654.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with an ultimate completion date of August 27, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA0MW
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML pharmaceutical products. The $3,375.96 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DoD).

Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025. This primary vehicle allows the company to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide. The current delivery order does not have a set-aside designation.

Generated 9/27/24, 9:22 AM